Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Jeffrey M. Dayno, M.D.$1.7B
Market Cap • 19/04/20242017
(há 7 anos)
2020
(4 years ago)
NASDAQ
Listagem
Plymouth Meeting
Sede • Pennsylvania200
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
HRMYSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.